Showing 5871-5880 of 10626 results for "".
- Blood Test Distinguishes Neuroendocrine Subtype of Advanced Prostate Cancerhttps://reachmd.com/news/blood-test-distinguishes-neuroendocrine-subtype-of-advanced-prostate-cancer/2456808/Credit: Unsplash/CC0 Public Domain Like a criminal entering a witness protection program, cancer cells can shed their past and take on a new identity. Detecting such an identity switch is particularly chall
- Size & Shape of Inhaled Asbestos Nanofibers May Be Exclusively Responsible for Pulmonary Fibrosishttps://reachmd.com/news/size-shape-of-inhaled-asbestos-nanofibers-may-be-exclusively-responsible-for-pulmonary-fibrosis/2456786/Pseudo-colored scanning electron microscopy image: phagocytosis by a macrophage (red) of glass nanofibers (blue) after 12 h of frustrated phagocytosis; scale bar, 5 μm. Credit: Nature Nan
- How COVID Skewed Maternal Death Statistics, Fueling False Claims About Abortionhttps://reachmd.com/news/how-covid-skewed-maternal-death-statistics-fueling-false-claims-about-abortion/2467985/IMAGE CAPTION: Protesters rally in Melbourne, Australia after Roe v. Wade was overturned. Credit: Creative Commons Federal statistics suggesting that maternal mortality rates plummeted after the overturning of Roe v. Wade are “highly misleading” and being misinterp
- How Some States Help Residents Avoid Costly Debt During Hard Timeshttps://reachmd.com/news/how-some-states-help-residents-avoid-costly-debt-during-hard-times/2467840/State variation in maximum UI benefits, average across states during Q2 2020–Q4 2021. Credit: Nature Human Behaviour (2024). DOI: 10.1038/s41562-024-01922-8 A new national study provides the best e
- Recalibrating Principles of Epigenetic Aging Clocks in Human Healthhttps://reachmd.com/news/recalibrating-principles-of-epigenetic-aging-clocks-in-human-health/2467822/Credit: 2024 Zhang et al. “Our study revealed that the composition of immune cells significantly affects the variation in EAA across six common blood epigenetic clocks.” BUFFALO, NY- August 14, 2024 – A new editorial was published in
- Fibromyalgia, IBS Patients Linked to Multiple-Drug Intolerancehttps://reachmd.com/news/fibromyalgia-ibs-patients-linked-to-multiple-drug-intolerance/2467051/(Photo credit: Getty Images) DALLAS – May 20, 2024 – Patients with fibromyalgia and irritable bowel syndrome (IBS) who take multiple medications are more likely to develop severe drug intolerance than healthy patients, UT Southwestern Medical
- HPV Vaccines Prevent Cancer in Men as Well as Women, New Research Suggestshttps://reachmd.com/news/hpv-vaccines-prevent-cancer-in-men-as-well-as-women-new-research-suggests/2463186/New research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are getting the shots in the United States.The HPV vaccine was developed to prevent cervical cancer in women and experts give it credit, along with scree
- New Insights into How Tumors on Adrenal Glands Develophttps://reachmd.com/news/new-insights-into-how-tumors-on-adrenal-glands-develop/2462570/Steroids-producing nodules, or SPNs, exhibit a two-layered zona fasciculata (zF) and zona reticularis (zR) like structure, where two distinct cell populations might contribute differently to adrenocortical tumorigenesis. Credit: Kyushu University/Oga
- Research Uncovers How to Target ‘Sleeping’ Breast Cancer Cells and Prevent Relapsehttps://reachmd.com/news/research-uncovers-how-to-target-sleeping-breast-cancer-cells-and-prevent-relapse/2462497/Image: Breast cancer cells. Credit: Anne Weston. Scientists have discovered how breast cancer cells can ‘hibernate’ to avoid treatment and ‘wake up’ years later – causing a relapse that is more difficult to treat. Their early stage research,
- Study Unlocks New Immunological Pathway for Treating Breast Cancer Bone Metastaseshttps://reachmd.com/news/study-unlocks-new-immunological-pathway-for-treating-breast-cancer-bone-metastases/2456941/Representative immunofluorescence staining of metastatic bone niche from LLC1 bone metastases bearing mouse (tumor region). Macrophage marker F4/80 (red), cancer (green), Siglec-15 (white) and nuclei (blue). Credit: Proceedings of the National Ac